F3Logic’s Ionis Pharmaceuticals IONS Stock Holding History

F3Logic’s Portfolio IONS Stock Details IONS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-28	Closed	-$1.33K	–	315
2020 Q3	$1.33K	Buy	+28	New	+$1.55K	0.03%	264

Other funds holding IONS

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

F3Logic's IONS Position: Q4 2020 in Review

F3Logic sold out of Ionis Pharmaceuticals (IONS) in Q4 2020, closing a stake of 28 shares — an estimated $1.33K sold.

F3Logic first reported a position in IONS in Q3 2020 and held it in 1 quarter. The position peaked at $1.33K in Q3 2020. 382 funds tracked by Wall St. Rank hold IONS as of Q4 2020.

F3Logic reported no remaining Ionis Pharmaceuticals position as of Q4 2020 after selling out during the quarter.
F3Logic sold 28 Ionis Pharmaceuticals shares in Q4 2020, an estimated $1.33K.
F3Logic first reported a position in Ionis Pharmaceuticals in Q3 2020 and held it in 1 quarter.
F3Logic's Ionis Pharmaceuticals position peaked at $1.33K in Q3 2020.
382 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q4 2020.

Based on F3Logic's 13F filing for Q4 2020, filed 12 Feb 2021.